SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PE Biosystems (PEB)
PEB 11.31-1.4%1:15 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Richard Haugland who wrote (79)10/6/1998 10:25:00 PM
From: Richard Haugland  Read Replies (2) of 122
 
FMAT System Provides Technology Access for Accelerated Pharmaceutical Lead Discovery

New Fluorometric Microvolume Assay Technology To Be Licensed

biz.yahoo.com

This is one of 3 press announcements from PKN that came out after the market making four for the day.

I am very impressed by the technology of Biometric Imaging that is the partner of PKN on the FMAT system. The company is not yet public but was started by the founder of Molecular Dynamics and other companies. The FMAT system has tremendous potential in high-throughput screening and other assays. It is a new direction for PKN but capitalizes on their expertise in instrumentation and fluorescence. I don't know if PKN has an investment in Biometric Imaging but it is a good partnership.

Neither short or long in PKN yet.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext